This Government Contract opportunity from Department Of Defense was posted on August 25, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Domestic Sourcing of Moxifloxacin Hydrochloride API
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The Defense Logistics Agency within the Department of Defense is seeking a subcontract for the domestic sourcing and supply of Moxifloxacin Hydrochloride Active Pharmaceutical Ingredient. This procurement is specifically governed by the Buy American Act and the Berry Amendment to ensure the materials are sourced domestically. The opportunity is categorized under NAICS code 325411 for pharmaceutical preparations. Interested parties must submit their responses by August 31, 2026, following the posting date of August 25, 2026.
General Info
Place of Performance
USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-4755.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
MOXIFLOXACIN HYDROCHLO
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
